Volume 20, Number 7—July 2014
Letter
Prevalence and Drug Resistance of Nontuberculous Mycobacteria, Northern China, 2008–2011
Table
Species and drug-resistance profiles of 95 nontuberculous mycobacteria strains, northern China, 2008–2011*
| Drugs | No. (%) resistant strains in Mycobacterium spp. |
Total | ||||||
|---|---|---|---|---|---|---|---|---|
| M. intracellulare | M.abscessus | M.fortuitum | M. gordonae | M.kansassi | M. avium | M.parascrofulaceum | ||
| INH | 37 (97.37) | 28 (100) | 7 (87.5) | 6 (75) | 3 (42.86) | 5 (100) | 1 (100) | 87 (91.58) |
| RIF | 34 (89.47) | 28 (100) | 7 (87.5) | 2 (25) | 0 | 5 (100) | 1 (100) | 77 (81.05) |
| EMB | 4 (10.53) | 26 (92.86) | 7 (87.5) | 1 (12.5) | 0 | 2 (40) | 0 | 40 (42.11) |
| SM | 38 (100) | 28 (100) | 7 (87.5) | 4 (50) | 6 (85.71) | 5 (100) | 1 (100) | 89 (93.68) |
| CPM | 31 (81.58) | 26 (92.86) | 4 (50) | 1 (12.5) | 2 (28.57) | 3 (60) | 1 (100) | 68 (71.58) |
| AK | 31 (81.58) | 25 (89.29) | 4 (50) | 1 (12.5) | 1 (14.29) | 4 (80) | 0 | 66 (69.43) |
| PTO | 25 (65.79) | 27 (96.43) | 6 (75) | 4 (50) | 0 | 4 (80) | 1 (100) | 67 (70.53) |
| PAS | 38 (100) | 28 (100) | 7 (87.5) | 8 (100) | 7 (100) | 4 (80) | 1 (100) | 93 (97.89) |
| OFLX | 38 (100) | 28 (100) | 3 (37.5) | 3 (37.5) | 1 (14.29) | 5 (100) | 1 (100) | 79 (83.16) |
| LVFX |
36 (94.74) |
28 (100) |
3 (37.5) |
2 (25) |
0 |
5 (100) |
1 (100) |
75 (78.95) |
| Total | 38 (40) | 28 (29.47) | 8 (8.42) | 8 (8.42) | 7 (7.37) | 5 (5.26) | 1 (1.05) | 95 (100) |
*INH, isoniazid; RIF, rifampin; EMB, ethambutol; SM, streptomycin; CPM, capreomycin; AK, amikacin; PTO, protionamide; PAS, para-aminosalicylic acid; OFLX, ofloxacin; LVFX, levofloxacin.
1These authors contributed equally to this article.
Page created: June 18, 2014
Page updated: June 18, 2014
Page reviewed: June 18, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.